Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens

scientific article published on 13 April 2016

Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.00529-16
P8608Fatcat IDrelease_iussaidmfbcbne6nsyca4warmi
P932PMC publication ID4922075
P698PubMed publication ID27076663

P50authorAndrew J VallelyQ37607022
Rebecca GuyQ58324757
Steven G BadmanQ58324761
P2093author name stringJ M Kaldor
J Allan
C Ryan
S N Tabrizi
H Wand
A Kelly-Hanku
A J Vallely
P Siba
S Silim
J Gabuzzi
B Kombuk
A Kumbia
G D L Mola
G Munnull
L Forereme
L M Vallely
P Toliman
Z Kombati
P2860cites workThe Measurement of Observer Agreement for Categorical DataQ26778373
WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer PreventionQ27015581
Global cancer statistics, 2012Q27860501
Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral populationQ30301116
Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopyQ30412457
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.Q33923869
HPV screening for cervical cancer in rural IndiaQ34973414
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatisQ37026425
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyQ37135912
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysisQ38179114
Achieving control of cervical cancer in Papua New Guinea: what are the research and program priorities?Q44346105
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialQ61626075
P433issue7
P407language of work or nameEnglishQ1860
P921main subjecthuman papillomavirus infectionQ184627
P304page(s)1734-1737
P577publication date2016-04-13
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleField Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens
P478volume54

Reverse relations

cites work (P2860)
Q95499867Q95499867
Q55241245A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening.
Q64097137Barriers to cervical cancer screening among rural women in eastern China: a qualitative study
Q92506705Cancer control in small island nations: from local challenges to global action
Q92506711Cancer control in the Pacific: big challenges facing small island states
Q92506700Cancer management in the Pacific region: a report on innovation and good practice
Q64264624Developing a culturally appropriate illustrated tool for the self-collection of anorectal specimens for the testing of sexually transmitted infections: lessons from Papua New Guinea
Q45074054Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
Q64274461Health service delivery models for scaling use of point-of-care HPV 'test and treat' strategies in high-burden, low-income settings
Q40370700High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study
Q89471393Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol
Q91629051Is It Relevant to Keep Advocating Visual Inspection of the Cervix With Acetic Acid for Primary Cervical Cancer Screening in Limited-Resource Settings?
Q58587240Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial le
Q48330261Performance of syndromic management for the detection and treatment of genital Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis among women attending antenatal, well woman and sexual health clinics in Papua New Guinea: a cross-
Q90313337Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana
Q28075858Point-of-Care Diagnostics for Improving Maternal Health in South Africa
Q47549030Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana
Q58800228Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda
Q37709706Recent advances in understanding and preventing human papillomavirus-related disease
Q54229599Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.
Q47129496The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary
Q38372381The time is now to implement HPV testing for primary screening in low resource settings